Erratum to: Different efficacy of EGFR tyrosine kinase inhibitors and prognosis in patients with subtypes of EGFR-mutated advanced non-small cell lung cancer: a meta-analysis

Samankaltaisia teoksia

• Different efficacy of EGFR tyrosine kinase inhibitors and prognosis in patients with subtypes of EGFR-mutated advanced non-small cell lung cancer: a meta-analysis
  Tekijä: Wang, Huan, et al.
  Julkaistu: (2014)
• Tumor Mutation Burden and Efficacy of EGFR-Tyrosine Kinase Inhibitors in Patients with EGFR-Mutant Lung Cancers.
  Tekijä: Offin, Michael, et al.
  Julkaistu: (2018)
• EGFR Mutation Status in Lung Adenocarcinoma-Associated Malignant Pleural Effusion and Efficacy of EGFR Tyrosine Kinase Inhibitors
  Tekijä: Yang, Jiyoul, et al.
  Julkaistu: (2018)
• BRIEF REPORT: Compound EGFR mutations and response to EGFR tyrosine kinase inhibitors
  Tekijä: Kobayashi, Susumu, et al.
  Julkaistu: (2013)
• Drug Tolerance to EGFR Tyrosine Kinase Inhibitors in Lung Cancers with EGFR Mutations
  Tekijä: Suda, Kenichi, et al.
  Julkaistu: (2021)